NCT01742611

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

ASP1585 Phase 3 Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 105 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

This is a multi-center, open-labeled, non-comparative study to examine the safety and efficacy of ASP1585 for long-term dosing in chronic kidney disease patients with hyperphosphatemia not on dialysis.

Conditions

• Chronic Kidney Disease
• Renal Insufficiency
• Hyperphosphatemia

Interventions

Type	Name	Description
DRUG	ASP1585	oral

Timeline

• Start date: 2013-03-01
• Primary completion: 2015-04-01
• Completion: 2015-04-01
• First posted: 2012-12-05
• Last updated: 2015-06-09

Locations

5 sites across 1 country: Japan